Entadfi™ (finasteride/tadalafil) – New drug approval
On December 13, 2021, Veru announced the FDA approval of Entadfi (finasteride/tadalafil), to initiate treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate for up to 26 weeks
Download PDF
